News > Research updates from the San Antonio Breast Cancer Symposium

Research updates from the San Antonio Breast Cancer Symposium

Hope Rugo, MD, speaks to LBBC about the most interesting findings presented at SABCS 2019

general_content

 

LBBC is joined by Hope S. Rugo, MD, director of the Breast Oncology Clinical Trials Program at University of California, San Francisco. Dr. Rugo speaks about some of the trials she has found most exciting at the San Antonio Breast Cancer Symposium, including results from the HER2CLIMB study of tucatinib in HER2 positive breast cancer in metastatic breast cancer and the Keynote-522 trial of the immunotherapy pembrolizumab (Keytruda) as well as new information about ado-trastuzumab emtansine (Kadcyla) in early stage breast cancer and a preview of a study coming Friday with the chemotherapy paclitaxel given as pills instead of infusion.

about_this_page_tabbed_module
About this page
Glossary
About LBBC

Hope S. Rugo, MD

  • Clinical professor of medicine at the University of California, San Francisco

  • Director of the Breast Medical Oncology Clinical Trials Program in the division of hematology and oncology at the University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center

Tagged:

Was this page helpful?

Living Beyond Breast Cancer is a national nonprofit organization that seeks to create a world that understands there is more than one way to have breast cancer. To fulfill its mission of providing trusted information and a community of support to those impacted by the disease, Living Beyond Breast Cancer offers on-demand emotional, practical, and evidence-based content. For over 30 years, the organization has remained committed to creating a culture of acceptance — where sharing the diversity of the lived experience of breast cancer fosters self-advocacy and hope. For more information, learn more about our programs and services.